Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
002581 Shandong Sinobioway Biomedicine
- 6.61
- +0.60+9.98%
Market Closed Apr 30 15:00 CST
4.36BMarket Cap-29.77P/E (TTM)
6.61High5.69Low429.47KlotVolume5.69Open6.01Pre Close269.79MTurnover10.72%Turnover RatioLossP/E (Static)659.74MShares14.4352wk High2.31P/B2.65BFloat Cap5.6952wk Low6.61Limit Up400.79MShs Float71.85Historical High5.41Limit Down15.31%Amplitude4.39Historical Low--Dividend TTM6.28Avg Price138.31KlotAsk--Div YieldTTM100Lot Size268.78KlotBid
Shandong Sinobioway Biomedicine News
Unnamed Pharmaceuticals: Announcement on Stock Price Changes and Risk Alerts
Unnamed Medicine: Legal Opinion of Zhejiang Tianzu (Shenzhen) Law Firm on the cancellation of some stock options from Shandong Weiming Biomedical Co., Ltd.\'s 2023 Stock Option Incentive Plan
Unnamed Pharmaceuticals: Notice on Convening the 2024 Annual General Meeting of Shareholders
Unnamed Pharmaceuticals: Independent Director Candidate Statements and Commitments - Cai Yanhong
Unnamed Medicine: Independent Director Candidate Statements and Commitments - Liu Yang
Unnamed Medicine: Independent Director Candidate Statements and Commitments - Xia Yang
Unnamed Pharmaceuticals: Announcement on the Disqualification of the Holding Subsidiary from Interprovincial Alliance Procurement Selection
Unnamed Pharmaceuticals: Supervisory Board\'s Inspection Opinions on Failure to Meet the Enforcement Conditions for the Second Term of the Company\'s 2023 Stock Options Incentive Plan and Cancellation of Some Stock Options
Unnamed Pharmaceuticals: Announcement of Board of Supervisory Committee Resolutions
Unnamed Pharmaceuticals: Independent Director Candidate Statements and Commitments - Zhang Rongfu
Unnamed Pharmaceuticals: Report for the first quarter of 2025
Unnamed Pharmaceuticals: Independent Director Nominee\'s Statement and Commitment - Xia Yang
Unnamed Pharmaceuticals: Independent Director Nominee\'s Statement and Commitment - Cai Yanhong
Unnamed Pharmaceutical: Announcement on the failure to fulfill the exercise conditions for the second exercise period of the 2023 Stock Options Incentive Plan and cancellation of some stock options
Unnamed Pharmaceuticals: Independent Director Nominee\'s Statement and Commitment - Zhang Rongfu
Unnamed Pharmaceuticals: Announcement on Board Election for a New Term
Unnamed Pharmaceuticals: Announcement of Board Resolutions
Unnamed Pharmaceuticals: Independent Director Nominee Statements and Commitments - Liu Yang
Unnamed Pharmaceuticals: Announcement on Suspension of Production, Sales and Risk Alerts by Holding Subsidiaries
Shandong Sinobioway Biomedicine: Special explanation from the Board of Directors regarding the matters involved in the non-standard audit opinion of the 2024 financial report.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts